PTEN Nuclear Localization Is Regulated by Oxidative Stress and Mediates p53-Dependent Tumor Suppression
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The tumor suppressor gene PTEN (phosphatase and tensin homologue deleted on chromosome 10) is frequently mutated or deleted in various human cancers. PTEN localizes predominantly to the cytoplasm and functions as a lipid phosphatase, thereby negatively regulating the phosphatidylinositol 3-kinase-AKT signaling pathway. PTEN can also localize to the nucleus, where it binds and regulates p53 protein level and transcription activity. However, the precise function of nuclear PTEN and the factors that control PTEN nuclear localization are still largely unknown. In this study, we identified oxidative stress as one of the physiological stimuli that regulate the accumulation of nuclear PTEN. Specifically, oxidative stress inhibits PTEN nuclear export, a process depending on phosphorylation of its amino acid residue Ser-380. Nuclear PTEN, independent of its phosphatase activity, leads to p53-mediated G(1) growth arrest, cell death, and reduction of reactive oxygen species production. Using xenografts propagated from human prostate cancer cell lines, we reveal that nuclear PTEN is sufficient to reduce tumor progression in vivo in a p53-dependent manner. The data outlined in this study suggest a unique role of nuclear PTEN to arrest and protect cells upon oxidative damage and to regulate tumorigenesis. Since tumor cells are constantly exposed to oxidative stress, our study elucidates the cooperative roles of nuclear PTEN with p53 in tumor suppression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Under oxidative stress, PTEN accumulates in the nucleus and can bind to p53, amplifying its function [89], [90].”
From Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer’s Disease (2014) · cites this paper as [89]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Chung, J.-H., Ginn-Pease, M. E., & Eng, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0124 · Cited by 164
RetractedChung, J.-H., Ostrowski, M. C., Romigh, T., Minaguchi, T., Waite, K. A., & Eng, C. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl177 · Cited by 112
RetractedLive or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Cellular response to oxidative stress: Signaling for suicide and survival*
Martindale, J. L., & Holbrook, N. J. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10119 · Cited by 2,297
The Multiple Roles of PTEN in Tumor Suppression
Di Cristofano, A., & Pandolfi, P. P. (2000) · Cell · doi:10.1016/s0092-8674(00)80674-1 · Cited by 1,182
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Crystal Structure of the PTEN Tumor Suppressor
Lee, J.-O., Yang, H., Georgescu, M.-M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J. E., Pandolfi, P., & Pavletich, N. P. (1999) · Cell · doi:10.1016/s0092-8674(00)81663-3 · Cited by 1,014
Essential role for nuclear PTEN in maintaining chromosomal integrity
Shen, W. H., Balajee, A. S., Wang, J., Wu, H., Eng, C., Pandolfi, P. P., & Yin, Y. (2007) · Cell · doi:10.1016/j.cell.2006.11.042 · Cited by 979
Self-citationThe Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Self-citation
Research works printed but not linked: 4
- Adey N. B., 2000, Cancer Res., 60, 35
- Ginn-Pease M. E., 2003, Cancer Res., 63, 282
- Maehama T., 2000, Tanpakushitsu Kakusan Koso, 45, 2405
- Mutter G. L., 2000, J. Clin. Endocrinol. Metab., 85, 2334
Cited by
Phosphoinositides: Tiny Lipids With Giant Impact on Cell Regulation
Balla, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00028.2012 · Cited by 1,638
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Worby, C. A., & Dixon, J. E. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-082411-113907 · Cited by 535
Inactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520
PTEN: a new guardian of the genome
Yin, Y., & Shen, W. H. (2008) · Oncogene · doi:10.1038/onc.2008.241 · Cited by 388
The role of PTEN signaling perturbations in cancer and in targeted therapy
Keniry, M., & Parsons, R. (2008) · Oncogene · doi:10.1038/onc.2008.248 · Cited by 358
The Tumor Suppressor PTEN Is Exported in Exosomes and Has Phosphatase Activity in Recipient Cells
Putz, U., Howitt, J., Doan, A., Goh, C.-P., Low, L.-H., Silke, J., & Tan, S.-S. (2012) · Science Signaling · doi:10.1126/scisignal.2003084 · Cited by 312
Chen, J.-H., Zhang, P., Chen, W.-D., Li, D.-D., Wu, X.-Q., Deng, R., Jiao, L., Li, X., Ji, J., Feng, G.-K., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1009767 · Cited by 162
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Bazzichetto, C., Conciatori, F., Pallocca, M., Falcone, I., Fanciulli, M., Cognetti, F., Milella, M., & Ciuffreda, L. (2019) · Cancers · doi:10.3390/cancers11040435 · Cited by 164
Ming, M., & He, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.003 · Cited by 168
Nuclear phosphoinositides: a signaling enigma wrapped in a compartmental conundrum
Barlow, C. A., Laishram, R. S., & Anderson, R. A. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.09.009 · Cited by 142
Dhar, S., Kumar, A., Li, K., Tzivion, G., & Levenson, A. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.11.004 · Cited by 146
Oxidative stress-related aging: A role for prostate cancer?
Minelli, A., Bellezza, I., Conte, C., & Čulig, Z. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.11.001 · Cited by 159
Kang, Y., Balter, B. B., Csizmadia, E., Haas, B. J., Sharma, H., Bronson, R. T., & Yan, C. T. (2017) · Nature Communications · doi:10.1038/ncomms15795 · Cited by 125
Zheng, H., Ying, H., Yan, H., Kimmelman, A. C., Hiller, D. J., Chen, A.-J., Perry, S. R., Tonon, G., Chu, G. C., Ding, Z., et al. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.047 · Cited by 124
Lafferty‐Whyte, K., Cairney, C. J., Jamieson, N. B., Oien, K. A., & Keith, W. N. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.02.003 · Cited by 124
Brandmaier, A., Hou, S., & Shen, W. H. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.06.004 · Cited by 119
Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 115
Targeting prostate cancer based on signal transduction and cell cycle pathways
Lee, J. T., Lehmann, B. D., Terrian, D. M., Chappell, W. H., Stivala, F., Libra, M., Martelli, A. M., Steelman, L. S., & McCubrey, J. A. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6166 · Cited by 118
Silva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99
Assinder, S. J., Dong, Q., Kovačević, Ž., & Richardson, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081610 · Cited by 107
Briest, F., & Grabowski, P. (2014) · Theranostics · doi:10.7150/thno.7851 · Cited by 100
Zhang, C., Jia, X., Bao, J., Chen, S., Wang, K., Zhang, Y., Li, P., Wan, J., Su, H., Wang, Y., et al. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1036-x · Cited by 98
Chae, H.-D., & Broxmeyer, H. E. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0465 · Cited by 92
Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression
Patel, R., Gao, M., Ahmad, I., Fleming, J., Singh, L. B., Singh, T., McKie, A. B., Seywright, M. M., Barnetson, R. J., Edwards, J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63672 · Cited by 93
Terrien, E., Chaffotte, A. F., Lafage, M., Khan, Z., Prehaud, C. J. N., Cordier, F., Simenel, C., Delepierre, M., BUC, H. C., Lafon, M., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002941 · Cited by 92
17βE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFκB-dependent pathway
Zhang, H., Ζhao, X., Liu, S., Li, J., Wen, Z., & Li, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.11.009 · Cited by 91
Nuclear Transport: A Switch for the Oxidative Stress—Signaling Circuit?
Kodiha, M., & Stochaj, U. (2011) · Journal of Signal Transduction · doi:10.1155/2012/208650 · Cited by 78
Wang, X., Cao, X., Sun, R., Tang, C., Tzankov, A., Zhang, J., Manyam, G. C., Xiao, M., Miao, Y., Jabbar, K. J., et al. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.002 · Cited by 69
Allele-specific tumor spectrum in Pten knockin mice
Wang, H., Karikomi, M., Naidu, S. K., Rajmohan, R., Caserta, E., Chen, H., Rawahneh, M., Moffitt, J., Stephens, J. A., Fernández, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912524107 · Cited by 66
Masse, I., Molin, L., Mouchiroud, L., Vanhems, P., Palladino, F., Billaud, M., & Solari, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003354 · Cited by 68
Τράκα, Μ., Spinks, C. A., Doleman, J. F., Melchini, A., Ball, R. Y., Mills, R., & Mithen, R. F. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-189 · Cited by 57
Effect of PTEN loss on metabolic reprogramming in prostate cancer cells
Xin Min, Z. H. O. U., Yang, X., Sun, X. Y., Xu, X., Li, X., Guo, Y. H., Wang, J., Li, X., Yao, L., Wang, H., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9932 · Cited by 62
Arun, R. P., Sivanesan, D., Vidyasekar, P., & Verma, R. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-06416-4 · Cited by 55
Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development
Frank, S. B., & Miranti, C. K. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00273 · Cited by 66
Rodríguez, J. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.005 · Cited by 51
Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA Repair
Minami, A., Nakanishi, A., Ogura, Y., Kitagishi, Y., & Matsuda, S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00318 · Cited by 54
Das, R., Bhattacharya, K., Sarkar, S., Samanta, S. K., Pal, B. C., & Mandal, C. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0907-6 · Cited by 46
RetractedPTEN Phosphorylation and Nuclear Export Mediate Free Fatty Acid-Induced Oxidative Stress
Wu, Y., Zhou, H., Wu, K., Lee, S., Li, R., & Liu, X. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5498 · Cited by 48
Vidimar, V., Gius, D. R., Chakravarti, D., Bulun, S. E., Wei, J., & Kim, J. J. (2016) · Science Advances · doi:10.1126/sciadv.1601132 · Cited by 49
Yavuz, B. R., Arici, M. K., Demirel, H. C., Tsai, C., Jang, H., Nussinov, R., & Tunçbağ, N. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00377-6 · Cited by 46
Multifaceted Regulation of PTEN Subcellular Distributions and Biological Functions
Liu, T., Wang, Y., Wang, Y., & Chan, A. M.-L. (2019) · Cancers · doi:10.3390/cancers11091247 · Cited by 43
PTEN attenuates PIP3/Akt signaling in the cochlea of the aging CBA/J mouse
Sha, S., Chen, F., & Schacht, J. (2009) · Hearing Research · doi:10.1016/j.heares.2009.09.002 · Cited by 41
The nuclear phosphoinositide response to stress
Chen, M., Wen, T., Horn, H. T., Chandrahas, V. K., Thapa, N., Choi, S., Cryns, V. L., & Anderson, R. A. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1711316 · Cited by 41
Exosome-based strategies for diagnosis and therapy of glioma cancer
Fath, M. K., Azami, J., Masoudi, A., Mosaddeghi-Heris, R., Rahmani, E., Alavi, F., Bahrami, A. A., Payandeh, Z., Khalesi, B., Dadkhah, M., et al. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02642-7 · Cited by 43
Lin, C.-C., Zhou, J., Liu, Y., Liu, J., Yang, X., Jazag, A., Zhang, Z., Guleng, B., & Ren, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051916 · Cited by 40
PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer
Malaney, P., Palumbo, E., Semidey-Hurtado, J., Hardee, J., Stanford, K., Kathiriya, J. J., Patel, D., Tian, Z., Allen‐Gipson, D., & Davé, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1388970 · Cited by 39
Hypoxic culture conditions enhance the generation of regulatory T cells
Neildez‐Nguyen, T. M. A., Bigot, J., Rocha, S. D., Corre, G., Boisgérault, F., Páldi, A., & Galy, A. H. M. (2014) · Immunology · doi:10.1111/imm.12388 · Cited by 37
Nongenomic Mechanisms of PTEN Regulation
Fata, J. E., Debnath, S., Jenkins, E. C., & Fournier, M. V. (2012) · International Journal of Cell Biology · doi:10.1155/2012/379685 · Cited by 39
Nuclear phosphoinositide regulation of chromatin
Hamann, B. L., & Blind, R. D. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25886 · Cited by 37
Campbell, L., Aljayyoussi, G., Gutteridge, R., Gumbleton, N., Griffiths, R., Gumbleton, S., Smith, M. W., Griffiths, D. F., & Gumbleton, M. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-255 · Cited by 36
Understanding the Tumor Suppressor PTEN in Chronic Alcoholism and Hepatocellular Carcinoma
Shearn, C. T., & Petersen, D. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_10 · Cited by 37
Wang, W., Liu, Y., Sun, M., Sai, N., You, L., Dong, X., Yin, X., & Ni, J. (2019) · Cells · doi:10.3390/cells8070690 · Cited by 34
Gil, A., Rodríguez‐Escudero, I., Stumpf, M., Molina, M., Cid, V. J., & Pulido, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119287 · Cited by 37
Varışlı, L., Gonen‐Korkmaz, C., Muhammed, H. S., Böğürcü, N., BÜTÜNER, B. D., Tepedelen, B. E., & Korkmaz, K. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.11.027 · Cited by 34
Calcium and Nuclear Signaling in Prostate Cancer
Maly, I. V., & Hofmann, W. A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041237 · Cited by 32
The role of the PTEN gene in malignant gliomas
Alexiou, G. Α., & Voulgaris, S. (2010) · Neurologia i Neurochirurgia Polska · doi:10.1016/s0028-3843(14)60408-4 · Cited by 32
Zeng, N., Li, Y., He, L., Xu, X., Galicia, V. A., Deng, C., & Stiles, B. L. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0299 · Cited by 32
Low, L., Chow, Y.-L., Li, Y., Goh, C., Putz, U., Silke, J., Ouchi, T., Howitt, J. A., & Tan, S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.613687 · Cited by 31
Nuclear trafficking of Pten after brain injury leads to neuron survival not death
Goh, C., Putz, U., Howitt, J. A., Low, L., Gunnersen, J. M., Bye, N., Morganti-Kossmann, M. C., & Tan, S. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.11.017 · Cited by 31
Qi, Y., Liu, X. J., Saadat, S., Tian, X., Han, Y., Fong, G.-H., Pandolfi, P. P., Lee, L. Y., & Li, S. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.185 · Cited by 31
Andrés‐Pons, A., Gil, A., Oliver, M. D., Sotelo, N. S., & Pulido, R. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.012 · Cited by 30
Ye, T., & Liang, B. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152943 · Cited by 33
Yu, W., He, X., Ni, Y., Ngeow, J. Y. Y., & Eng, C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu425 · Cited by 32
Nuclear PTEN’s Functions in Suppressing Tumorigenesis: Implications for Rare Cancers
Langdon, C. G. (2023) · Biomolecules · doi:10.3390/biom13020259 · Cited by 29
Kang, Y., Balter, B. B., Csizmadia, E., Haas, B. J., Sharma, H., Bronson, R. T., & Yan, C. T. (2017) · Nature Communications · doi:10.1038/ncomms14013 · Cited by 27
Li, H., Weidong, L., Zhang, G., Liu, R., Qu, M., Zhang, J., & Xing, X. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10599-x · Cited by 26
Gunaratne, J., Goh, M. X., Swa, H. L. F., Lee, F. Y., Sanford, E., Wong, L. M., Hogue, K. A., Blackstock, W. P., & Okumura, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.221184 · Cited by 26
Kato, T., Yamada, T., Nakamura, H., Igarashi, A., Anders, R. A., Sesaki, H., & Iijima, M. (2020) · iScience · doi:10.1016/j.isci.2020.101548 · Cited by 26
Roy, D., & Dittmer, D. P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.06.017 · Cited by 26
The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets
Liu, J., Pan, Y., Liu, Y., Wei, W., Hu, X., Xin, W., & Chen, N. (2023) · Journal of Cellular Physiology · doi:10.1002/jcp.31053 · Cited by 28
Wu, M., Chen, Y., Chen, H.-H., Chang, K.-W., Chang, I.-S., Wang, L., & Hsu, H. L. (2014) · Oncogene · doi:10.1038/onc.2014.125 · Cited by 25
Al-attar, R., Childers, C. L., Nguyen, V. C., Pamenter, M. E., & Storey, K. B. (2020) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2020.110653 · Cited by 24
Non-canonical function of nuclear PTEN and its implication on tumorigenesis
Misra, S., Ghosh, G., Chowdhury, S. G., & Karmakar, P. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103197 · Cited by 24
Anti-diabetic effect of Alpinia oxyphylla extract on 57BL/KsJ db-/db- mice
Xie, Y., Xiao, M., Li, D., Liu, H., Yun, F., Yi, W., Sang, S., & Du, G. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4152 · Cited by 24
Khamis, Z. I., Iczkowski, K. A., & Sang, Q. A. (2011) · Medicinal Research Reviews · doi:10.1002/med.20232 · Cited by 24
Characterization of a novel PTEN mutation in MDA-MB-453 breast carcinoma cell line
Singh, G., Odriozola, L., Guan, H., Kennedy, C. R., & Chan, A. M.-L. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-490 · Cited by 29
Yang, C., Li, S., Wang, M., Chang, A. K., Liu, Y., Zhao, F. H., Xiao, L., Han, L., Wang, D., Li, S., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-21 · Cited by 24
Self-citationMutational analysis of p53 and PTEN in soft tissue sarcoma
Li, F. (2011) · Molecular Medicine Reports · doi:10.3892/mmr.2011.660 · Cited by 23
Establishment of a novel cellular model for myxofibrosarcoma heterogeneity
Lohberger, B., Stuendl, N., Leithner, A., Rinner, B., Sauer, S., Kashofer, K., & Liegl‐Atzwanger, B. (2017) · Scientific Reports · doi:10.1038/srep44700 · Cited by 25
The non‐canonical nuclear functions of key players of the PI3K‐AKT‐MTOR pathway
Gupta, S., Kumar, M. K., Chaudhuri, S., & Kumar, A. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30782 · Cited by 23
NFBTA: A Potent Cytotoxic Agent against Glioblastoma
Türkez, H., da Nóbrega, F. R., Tozlu, Ö. Ö., Filho, C. D. S. M. B., de Almeida, R. N., Tejera, E., Pérez‐Castillo, Y., & de Sousa, D. P. (2019) · Molecules · doi:10.3390/molecules24132411 · Cited by 22
Mosessian, S., Avliyakulov, N. K., Mulholland, D. J., Boontheung, P., Loo, J. A., & Wu, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027995 · Cited by 22
Self-citationZhong, J., Kang, Q., Cao, Y., He, B., Zhao, P., Gou, Y., Luo, Y., He, T., & Fan, J. (2021) · PubMed · Cited by 21
Malaney, P., Uversky, V. N., & Davé, V. (2015) · Methods · doi:10.1016/j.ymeth.2014.10.005 · Cited by 18
Myosin 1b Regulates Nuclear AKT Activation by Preventing Localization of PTEN in the Nucleus
Yu, Y., Xiong, Y., Ladeiras, D., Yang, Z., & Ming, X. (2019) · iScience · doi:10.1016/j.isci.2019.07.010 · Cited by 18
Wu, X., Rahal, O. M., Kang, J., Till, S. R., Prior, R. L., & Simmen, R. C. M. (2009) · Nutrition Research · doi:10.1016/j.nutres.2009.10.015 · Cited by 17
Phosphorylation of PTEN at STT motif is associated with DNA damage response
Misra, S., Mukherjee, A., & Karmakar, P. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.08.008 · Cited by 17
PTEN, Longevity and Age-Related Diseases
Tait, I., Li, Y., & Lu, J. (2013) · Biomedicines · doi:10.3390/biomedicines1010017 · Cited by 17
Cell Cycle Regulation via the p53, PTEN, and BRCA1 Tumor Suppressors
Minami, A., Murai, T., Nakanishi, A., Kitagishi, Y., Ichimura‐Shimizu, M., & Matsuda, S. (2016) · InTech eBooks · doi:10.5772/61116 · Cited by 16
Unique properties of PTEN-L contribute to neuroprotection in response to ischemic-like stress
Jochner, M. C. E., An, J., Lättig-Tünnemann, G., Kirchner, M., Dagane, A., Dittmar, G., Dirnagl, U., Eickholt, B. J., & Harms, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39438-1 · Cited by 16
Reactive Oxygen Species: Friends and Foes of Signal Transduction
Retta, S. F., Chiarugi, P., Trabalzini, L., Pinton, P., & Belkin, A. M. (2012) · Journal of Signal Transduction · doi:10.1155/2012/534029 · Cited by 16
Loss of nuclear PTEN in HCV-infected human hepatocytes
Bao, W., Florea, L., Wu, N., Wang, Z., Banaudha, K. K., Qian, J., Houzet, L., Kumar, R., & Kumar, A. (2014) · Infectious Agents and Cancer · doi:10.1186/1750-9378-9-23 · Cited by 15
Kılıç, K. D., Garipoğlu, G., Çakar, B., Uyanıkgil, Y., & Erbaş, O. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10190-w · Cited by 15
Liu, Y., Yao, S., Zhao, Y., Yao, Z., Ma, J., Xia, Q., Fu, K., & Yang, S. (2010) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2010.502584 · Cited by 14
Hanna, C., Dunne, V. L., Walker, S. M., Butterworth, K. T., McCabe, N., Waugh, D. J. J., Kennedy, R. D., & Prise, K. M. (2020) · Cancers · doi:10.3390/cancers13010079 · Cited by 13
Is Cytoplasmic PTEN a Specific Target for Neuronal Survival?
Krishnan, A., & Zochodne, D. W. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8922-3 · Cited by 12
Zhang, J., Yang, C., Zhou, F., & Chen, X. (2018) · Oncology Reports · doi:10.3892/or.2018.6369 · Cited by 12
Day, E. K., Zhong, Q., Purow, B. W., & Lazzara, M. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1756 · Cited by 10
Zhang, H., Siu, M. K.-Y., Jiang, L., Mak, V. C. Y., Ngan, H., & Cheung, A. (2010) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e3181de3068 · Cited by 10
Metadata
- Authors
- Chang, C.-J., Mulholland, D. J., Valamehr, B., Mosessian, S., Sellers, W. R., & Wu, H.
- Affiliations
- University of California, Los Angeles (US)
- Harvard University (US)
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-05-01
- Volume
- 28
- Issue
- 10
- Pages
- 3281-3289
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2423144
- OpenAlex
- W2131234404
- Cited by
- 155
- References
- 41
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 2 · 2023: 11 · 2022: 3 · 2021: 6 · 2020: 12 · 2019: 7 · 2018: 3 · 2017: 9 · 2016: 8 · 2015: 7 · 2014: 20 · 2013: 12 · 2012: 11
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense
- National Institutes of Health (NIH P50, CA86306)
- U.S. Public Health Service
- National Cancer Institute (P50 CA86306, CA 092131, CA107166:01S1, CA86306, R01CA107166, P50CA086306, F32CA112988, P50CA092131, CA107166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- PTEN, nuclear localization, oxidative stress, p53, tumor suppression, nuclear export, G1 cell cycle arrest, reactive oxygen species, prostate cancer, phosphatidylinositol 3-kinase/Akt signaling
- MeSH terms
- Animals, Base Sequence, Cell Cycle, Cell Nucleus, Cells, Cultured, Humans, Male, Models, Biological, Neoplasm Transplantation, Prostatic Neoplasms, Transplantation, Heterologous, Genes, p53, Tumor Suppressor Protein p53, Mice, SCID, Apoptosis, DNA Primers, Mice, Knockout, Oxidative Stress, Active Transport, Cell Nucleus, Cell Line, Tumor, PTEN Phosphohydrolase, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.